Ieq Capital »

Inhibikase Therapeutics shares owned by Ieq Capital

Quarter-by-quarter ownership of Inhibikase Therapeutics (IKT) shares owned by Ieq Capital from 13F filings

Historical chart of Ieq Capital investment in Inhibikase Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Inhibikase Therapeutics held by Ieq Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Inhibikase Therapeutics by Ieq Capital

Quarter filed Position value Share count Share price at filing
2026-03-31 $27k 16k 1.68

More positions owned by Ieq Capital

Roblox Corp Cl A (RBLX)
NVIDIA Corporation (NVDA)
Apple (AAPL)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Meta Platforms Cl A (META)
Microsoft Corporation (MSFT)
Spdr Series Trust State Street Spd (BIL)
Amazon (AMZN)
Vanguard Index Fds Total Stk Mkt (VTI)
Alphabet Cap Stk Cl A (GOOGL)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Alphabet Cap Stk Cl C (GOOG)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Broadcom (AVGO)
Crowdstrike Hldgs Cl A (CRWD)

View all positions for Ieq Capital

Top funds holding Inhibikase Therapeutics

Sands Capital Ventures
Soleus Capital Management
Fairmount Funds Management
Trails Edge Capital Partners
ADAR1 Capital Management
BlackRock
Blackstone Group
Siren
Commodore Capital
Vanguard Capital Management
Saturn V Capital Management
Kalehua Capital Management
Squadron Capital Management
Millennium Management
Nantahala Capital Management

View all funds holding Inhibikase Therapeutics